CURIS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- CURIS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-06-30 was 0.00 shares.
- CURIS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-03-31 was 0.00 shares.
- CURIS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-12-31 was 0.00 shares.
- CURIS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-09-30 was 0.00 shares.
- CURIS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 0.00 shares.
- CURIS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 0.00 shares, a 100.00% decline from fiscal 2023.
- CURIS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 515.00 shares.
- CURIS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 0.00 shares, a 100.00% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2026-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | 0.00 shares derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | 0.00 shares 10-Q · filed 2026-05-13 | 0.00 shares derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | 0.00 shares 10-K · filed 2026-03-24 |
| 2025-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | 0.00 shares derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | 0.00 shares derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | 0.00 shares 10-Q · filed 2026-05-13 | 0.00 shares derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | 0.00 shares 10-K · filed 2025-03-31 |
| 2024-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | 0.00 shares derived: sum of 4 quarters · filed 2024-11-14 |
| 2024-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | -9.80K shares derived: sum of 4 quarters · filed 2024-08-01 |
| 2024-03-31 | 0.00 shares 10-Q · filed 2024-05-07 | -9.80K shares derived: sum of 4 quarters · filed 2024-05-07 |
| 2023-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-08 | 515.00 shares 10-K · filed 2024-02-08 |
| 2023-09-30 | -9.80K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | 515.00 shares derived: sum of 4 quarters · filed 2023-11-02 |
| 2023-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | 10.31K shares derived: sum of 4 quarters · filed 2023-08-03 |
| 2023-03-31 | 10.31K shares 10-Q · filed 2023-05-04 | 10.31K shares derived: sum of 4 quarters · filed 2023-05-04 |
| 2022-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-13 | 0.00 shares 10-K · filed 2023-03-13 |
| 2022-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | 13.13K shares derived: sum of 4 quarters · filed 2022-11-09 |
| 2022-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | 25.93K shares derived: sum of 4 quarters · filed 2022-08-04 |
| 2022-03-31 | 0.00 shares 10-Q · filed 2022-05-05 | 67.24K shares derived: sum of 4 quarters · filed 2022-05-05 |
| 2021-12-31 | 13.13K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | 98.89K shares 10-K · filed 2022-02-24 |
| 2021-09-30 | 12.80K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | 461.72K shares derived: sum of 4 quarters · filed 2021-11-09 |
| 2021-06-30 | 41.31K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | 448.92K shares derived: sum of 4 quarters · filed 2021-08-03 |
| 2021-03-31 | 31.65K shares 10-Q · filed 2021-05-12 | 422.77K shares derived: sum of 4 quarters · filed 2021-05-12 |
| 2020-12-31 | 375.97K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | 391.12K shares 10-K · filed 2021-03-16 |
| 2020-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | 15.16K shares derived: sum of 4 quarters · filed 2021-05-12 |
| 2020-06-30 | 15.16K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | 15.16K shares derived: sum of 4 quarters · filed 2021-05-12 |
| 2020-03-31 | 0.00 shares 10-Q · filed 2021-05-12 | 0.00 shares derived: sum of 4 quarters · filed 2021-05-12 |
| 2019-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-19 | 0.00 shares 10-K · filed 2020-03-19 |
| 2019-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | 0.00 shares derived: sum of 4 quarters · filed 2019-11-05 |
| 2019-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | 0.00 shares derived: sum of 4 quarters · filed 2019-08-09 |
| 2019-03-31 | 0.00 shares 10-Q · filed 2019-05-14 | 0.00 shares derived: sum of 4 quarters · filed 2019-05-14 |
| 2018-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-26 | 0.00 shares 10-K · filed 2019-03-26 |
| 2018-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | 0.00 shares derived: sum of 4 quarters · filed 2018-11-01 |
| 2018-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | 104.80K shares derived: sum of 4 quarters · filed 2018-08-02 |
| 2018-03-31 | 0.00 shares 10-Q · filed 2018-05-03 | 330.98K shares derived: sum of 4 quarters · filed 2018-05-03 |
| 2017-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | 780.13K shares 10-K · filed 2018-03-08 |
| 2017-09-30 | 104.80K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | |
| 2017-06-30 | 226.18K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | |
| 2017-03-31 | 449.15K shares 10-Q · filed 2017-05-04 | |
| 2016-12-31 | 1.83M shares 10-K · filed 2017-03-09 | |
| 2015-12-31 | 695.34K shares 10-K · filed 2016-02-29 | |
| 2014-12-31 | 114.81K shares 10-K · filed 2015-02-24 | |
| 2013-12-31 | 2.12M shares 10-K · filed 2014-03-13 | |
| 2012-12-31 | 2.19M shares 10-K · filed 2013-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |